181 related articles for article (PubMed ID: 8943866)
41. Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?
Pagano L; Pulsoni A; Tosti ME; Mele A; Mele L; Corvatta L; Miraglia E; Almici C; Manna A; Del Poeta G; Lanza F; Masini L; Recchia A; Equitani F; Leone G; Mandelli F;
Hematol J; 2000; 1(5):329-32. PubMed ID: 11920210
[TBL] [Abstract][Full Text] [Related]
42. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
Le Beau MM; Albain KS; Larson RA; Vardiman JW; Davis EM; Blough RR; Golomb HM; Rowley JD
J Clin Oncol; 1986 Mar; 4(3):325-45. PubMed ID: 3950675
[TBL] [Abstract][Full Text] [Related]
43. Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.
Pedersen-Bjergaard J; Andersen MT; Andersen MK
Hematology Am Soc Hematol Educ Program; 2007; ():392-7. PubMed ID: 18024656
[TBL] [Abstract][Full Text] [Related]
44. TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities.
Kaneko H; Misawa S; Horiike S; Nakai H; Kashima K
Blood; 1995 Apr; 85(8):2189-93. PubMed ID: 7718890
[TBL] [Abstract][Full Text] [Related]
45. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
46. Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.
Mori N; Hidai H; Yokota J; Okada M; Motoji T; Oshimi K; Mizoguchi H
Leuk Res; 1995 Nov; 19(11):869-75. PubMed ID: 8551805
[TBL] [Abstract][Full Text] [Related]
47. Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.
Zompi S; Viguié F
Leuk Lymphoma; 2002 Feb; 43(2):275-80. PubMed ID: 11999558
[TBL] [Abstract][Full Text] [Related]
48. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.
Harada H; Harada Y; Tanaka H; Kimura A; Inaba T
Blood; 2003 Jan; 101(2):673-80. PubMed ID: 12393679
[TBL] [Abstract][Full Text] [Related]
49. High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome.
Sheikhha MH; Tobal K; Liu Yin JA
Br J Haematol; 2002 May; 117(2):359-65. PubMed ID: 11972518
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review.
Pedersen-Bjergaard J
Leuk Res; 1992; 16(1):61-5. PubMed ID: 1732675
[TBL] [Abstract][Full Text] [Related]
51. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.
Zhu YM; Das-Gupta EP; Russell NH
Blood; 1999 Jul; 94(2):733-40. PubMed ID: 10397740
[TBL] [Abstract][Full Text] [Related]
52. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
53. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.
Kantarjian HM; Keating MJ; Walters RS; Smith TL; Cork A; McCredie KB; Freireich EJ
J Clin Oncol; 1986 Dec; 4(12):1748-57. PubMed ID: 3783201
[TBL] [Abstract][Full Text] [Related]
54. Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS).
Kawashiri T; Kobayashi D; Uchida M; Hiromoto S; Inoue M; Ikeda H; Inoue M; Shimazoe T
J Pharm Pharm Sci; 2021; 24():499-508. PubMed ID: 34644524
[TBL] [Abstract][Full Text] [Related]
55. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
Borthakur G; Estey AE
Curr Oncol Rep; 2007 Sep; 9(5):373-7. PubMed ID: 17706165
[TBL] [Abstract][Full Text] [Related]
56. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.
Krishnan A; Bhatia S; Slovak ML; Arber DA; Niland JC; Nademanee A; Fung H; Bhatia R; Kashyap A; Molina A; O'Donnell MR; Parker PA; Sniecinski I; Snyder DS; Spielberger R; Stein A; Forman SJ
Blood; 2000 Mar; 95(5):1588-93. PubMed ID: 10688812
[TBL] [Abstract][Full Text] [Related]
57. Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome.
Casorelli I; Offman J; Mele L; Pagano L; Sica S; D'Errico M; Giannini G; Leone G; Bignami M; Karran P
DNA Repair (Amst); 2003 May; 2(5):547-59. PubMed ID: 12713812
[TBL] [Abstract][Full Text] [Related]
58. Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms.
Gafanovich A; Ramu N; Krichevsky S; Pe'er J; Amir G; Ben-Yehuda D
Cancer; 1999 Jan; 85(2):504-10. PubMed ID: 10023722
[TBL] [Abstract][Full Text] [Related]
59. Comments on the paper: Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors--a biological perspective.
Plumb M
Int J Radiat Biol; 2003 May; 79(5):367-70; author reply 371-4. PubMed ID: 12943245
[No Abstract] [Full Text] [Related]
60. Field cancerization: why late "recurrent" ovarian cancer is not recurrent.
Buller RE; Skilling JS; Sood AK; Plaxe S; Baergen RN; Lager DJ
Am J Obstet Gynecol; 1998 Apr; 178(4):641-9. PubMed ID: 9579425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
